Clinical Trial Update: RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW) [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial is evaluating a radiolabeled perfusion tracer to identify coronary artery disease using water-based imaging. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• RAPID-WATER-FLOW tracer (investigational radiopharmaceutical)

Snippet

Sponsor: MedTrace Pharma A/S | Conditions: Coronary Artery Disease | Phase 3 | Status: RECRUITING